Titan Medical Inc. (TMDI)
Stock Price:
$1.40 USD
0.00 (0.00%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $1.34 -0.06 (-4.29%) Dec 3, 7:49 PM
Key Info
| Market Cap |
114.22M |
| Revenue (ttm) |
10.00M |
| Net Income (ttm) |
-41.91M |
| Shares Out |
30.69M |
| EPS (ttm) |
-0.02 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
December 3 |
| Last Price |
$1.40 |
| Previous Close |
$1.40 |
| Change ($) |
0.00 |
| Change (%) |
0.00% |
| Day's Open |
1.34 |
| Day's Range |
1.30 - 1.45 |
| Day's Volume |
884,531 |
| 52-Week Range |
0.15 - 1.59 |
More Stats
| Market Cap |
114.22M |
| Enterprise Value |
112.95M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
30.69M |
| Float |
n/a |
| EPS (basic) |
-1.37 |
| EPS (diluted) |
-0.02 |
| FCF / Share |
-1.50 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
994,539 |
| Short Ratio |
2.76 |
| Short % of Float |
n/a |
| Beta |
4.32 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
11.42 |
| PB Ratio |
35.14 |
| Revenue |
10.00M |
| Operating Income |
-59.27M |
| Net Income |
-41.91M |
| Free Cash Flow |
-45.96M |
| Net Cash |
1.27M |
| Net Cash / Share |
0.02 |
| Gross Margin |
n/a |
| Operating Margin |
-592.65% |
| Profit Margin |
n/a |
| FCF Margin |
-459.60% |
| ROA |
-4.97% |
| ROE |
n/a |
| ROIC |
264.00% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (1)
| Buy |
0 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Low
1.00
Current: $1.40
High
1.00
Target: 1.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | - | - | - |
| Operating Income | -59.27 | -39.69 | -18.88 |
| Net Income | -41.91 | -22.64 | -33.59 |
| Shares Outstanding | 30.69 | 16.64 | 7.90 |
| Earnings Per Share | -1.37 | -1.36 | -4.25 |
| Operating Cash Flow | -45.96 | -41.40 | -19.09 |
| Capital Expenditures | - | - | - |
| Free Cash Flow | -45.96 | -41.40 | -19.09 |
| Cash & Equivalents | 1.30 | 20.01 | 28.67 |
| Total Debt | 0.02 | - | - |
| Net Cash / Debt | 1.27 | 20.01 | 28.67 |
| Assets | 3.38 | 21.92 | 29.67 |
| Liabilities | 15.06 | 17.70 | 20.07 |
| Book Value | -11.68 | 4.22 | 9.61 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Titan Medical Inc. |
| CEO |
David McNally |
Stock Information
| Ticker Symbol |
TMDI |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: TMDI |
Description
Titan Medical, a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.